ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,17
-0,13%
Dow Jones
42.313,00
0,33%
Euro vs US Dollar
1,11645
-0,10%
Bitcoin
65.784,20
0,92%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Kali Inc (CE) (KALY)

  7. Kali Inc (CE) (KALY) News

KALY

Kali (CE) (KALY)

Kali Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:KALY
DatumZeitQuelleÜberschriftSymbolFirma
06/05/202119h17InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership HighlightsUSOTC:KALYKali Inc (CE)
05/05/202119h30InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Rollout Preview This Friday To Include ALKM and USMJ Partnership UpdatesUSOTC:KALYKali Inc (CE)
03/05/202121h22InvestorsHub NewsWirePAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This FridayUSOTC:KALYKali Inc (CE)
13/04/202115h35InvestorsHub NewsWirePAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction TechnologyUSOTC:KALYKali Inc (CE)
12/04/202114h43InvestorsHub NewsWirePAOG Signals BUY - CBD Pharma Development Backed US PatentUSOTC:KALYKali Inc (CE)
08/04/202114h57InvestorsHub NewsWirePAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On TrackUSOTC:KALYKali Inc (CE)
16/03/202114h17InvestorsHub NewsWirePAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJUSOTC:KALYKali Inc (CE)
10/03/202119h42InvestorsHub NewsWirePAOG Announces Save The Date For CBD Nutraceuticals Expansion UpdateUSOTC:KALYKali Inc (CE)
08/03/202117h32InvestorsHub NewsWirePAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment MarketUSOTC:KALYKali Inc (CE)
03/02/202114h37InvestorsHub Cannabis NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
03/02/202114h37InvestorsHub NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
27/01/202115h18InvestorsHub Cannabis NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
27/01/202115h18InvestorsHub NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
20/01/202115h52InvestorsHub Cannabis NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
20/01/202115h52InvestorsHub NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
13/01/202117h22InvestorsHub NewsWirePAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update TomorrowUSOTC:KALYKali Inc (CE)
11/01/202117h10InvestorsHub NewsWirePAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2...USOTC:KALYKali Inc (CE)
22/12/202017h57InvestorsHub NewsWirePAOG Expects To Report First Post Acquisition Revenue In Q4 2020USOTC:KALYKali Inc (CE)
18/12/202015h10InvestorsHub NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
18/12/202015h10InvestorsHub Cannabis NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
17/12/202018h34InvestorsHub Cannabis NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
17/12/202018h34InvestorsHub NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
17/11/202015h41InvestorsHub NewsWirePAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend DistributionUSOTC:KALYKali Inc (CE)
23/10/202016h24InvestorsHub NewsWirePAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory ApprovalUSOTC:KALYKali Inc (CE)
21/10/202015h59InvestorsHub NewsWirePAOG Cannabis Drug Company Trends Bullish - $0.01 Breakout On Horizon?USOTC:KALYKali Inc (CE)
16/10/202019h46InvestorsHub NewsWirePAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp AwarenessUSOTC:KALYKali Inc (CE)
15/10/202015h44InvestorsHub NewsWirePAOG Releases Cannabis Drug Development UpdateUSOTC:KALYKali Inc (CE)
05/10/202017h24InvestorsHub Cannabis NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
05/10/202017h24InvestorsHub NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
30/09/202016h20InvestorsHub NewsWirePAOG Cannabis Pharmaceutical Research Initiative Gains New TractionUSOTC:KALYKali Inc (CE)
 Showing the most relevant articles for your search:USOTC:KALY

Kürzlich von Ihnen besucht

NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
TG
BAYN
Bayer
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
MRK
Merck
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
TG
DTE
Deutsche Telekom
DBI
DAX
DAX
TG
ALV
Allianz
TG
CBK
Commerzbank
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten